Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study

Inhibition of angiotensin II synthesis seems to decrease hepatocellular carcinoma recurrence after radical therapies; however, data on the adjuvant role of angiotensin II receptor 1 blockers (sartans) are still lacking. Aim of the study was to evaluate whether sartans delay time to recurrence and pr...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Antonio Facciorusso, Mohamed A. Abd El Aziz, Ivan Cincione, Ugo Vittorio Cea, Alessandro Germini, Stefano Granieri, Christian Cotsoglou, Rodolfo Sacco
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Subjects:	sartans liver cancer HCC RFA survival
Online Access:	https://www.mdpi.com/2227-9059/8/10/399